{"id":"W4379346220","doi":"10.1200/jco.2023.41.16_suppl.e21519","title":"Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Progression-free survival; Discontinuation; Population; Adverse effect; Hazard ratio; Cohort; Proportional hazards model; Log-rank test; Exact test; Cancer; Immunotherapy; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003894812,0.0002258491,0.002264708,0.000510495,0.00005017908,0.000007259037,0.0002613537,0.0003176548,0.0001142562],"category_scores_gemma":[0.006571916,0.0001751271,0.0006918253,0.0008452046,0.0002780606,0.0001394947,0.0001979784,0.001682808,0.0001278585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007414716,"about_ca_system_score_gemma":0.001874776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002600485,"about_ca_topic_score_gemma":0.0007781154,"domain_scores_codex":[0.9940276,0.0004133761,0.004189331,0.0003287598,0.0005479463,0.00049305],"domain_scores_gemma":[0.990716,0.006221257,0.002025228,0.000340831,0.0003513267,0.0003452985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007145145,0.001175122,0.8949295,0.0001889382,0.00009014281,0.02135334,0.0005957693,0.0001466356,0.002088983,0.00001742806,0.007454747,0.06481428],"study_design_scores_gemma":[0.008228903,0.01169608,0.9539137,0.0003607886,0.0002066663,0.0007018801,0.0006197327,0.00005894111,0.001965589,0.0002036175,0.02185785,0.0001861955],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726741,0.002931553,0.000003194127,0.009291085,0.003493268,0.0003162232,0.000001665038,0.00002758927,0.01126133],"genre_scores_gemma":[0.9908274,0.003740988,0.001070589,0.0005104478,0.001787781,0.0000123867,0.000001296068,0.00003679535,0.002012345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06462809,"threshold_uncertainty_score":0.7867672,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1081467984445015,"score_gpt":0.4475976401977972,"score_spread":0.3394508417532957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}